Cargando…
Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer
OBJECTIVE: Breast cancer is one of the most common malignancies in women worldwide. It is caused by a number of genetic and epigenetic factors. Aberrant hypermethylation of the promoter regions in specific genes is a key event in the formation and progression of breast cancers as well as the DBC2 ge...
Autores principales: | Hajikhan Mirzaei, Mehri, Noruzinia, Mehrdad, Karbassian, Hamid, Shafeghati, Yousef, Keyhanee, Mousa, Bidmeshki-Pour, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635816/ https://www.ncbi.nlm.nih.gov/pubmed/23626933 |
Ejemplares similares
-
Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer
por: Izadi, Pantea, et al.
Publicado: (2012) -
Fanconi-Bickel syndrome versus osteogenesis imperfeeta: An Iranian case with a novel mutation in glucose transporter 2 gene, and review of literature
por: Hadipour, Fatemeh, et al.
Publicado: (2013) -
Expression of SIRT1 and DBC1 in Developing and Adult Retinas
por: Maloney, Shawn C., et al.
Publicado: (2012) -
Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma
por: Kang, Youngran, et al.
Publicado: (2012) -
DbcAMP regulates adipogenesis in sheep inguinal preadipocytes
por: Kong, Delin, et al.
Publicado: (2017)